Published in Biomaterials on November 13, 2008
Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol (2012) 3.48
The nanosilica hazard: another variable entity. Part Fibre Toxicol (2010) 2.38
The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomedicine (2012) 2.29
Protein-nanoparticle interactions: What does the cell see? Nat Nanotechnol (2009) 2.00
Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nat Nanotechnol (2010) 2.00
PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics. Nano Lett (2012) 1.77
Nanomaterial cytotoxicity is composition, size, and cell type dependent. Part Fibre Toxicol (2010) 1.75
The new toxicology of sophisticated materials: nanotoxicology and beyond. Toxicol Sci (2010) 1.71
Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle. J Nanobiotechnology (2013) 1.57
Effects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell lines. PLoS One (2011) 1.36
Endocytosis and exocytosis of nanoparticles in mammalian cells. Int J Nanomedicine (2014) 1.34
Gold nanoparticles delivery in mammalian live cells: a critical review. Nano Rev (2010) 1.25
Physical and chemical strategies for therapeutic delivery by using polymeric nanoparticles. Pharmacol Rev (2012) 1.15
Silver nanoparticle protein corona composition in cell culture media. PLoS One (2013) 1.13
New views on cellular uptake and trafficking of manufactured nanoparticles. J R Soc Interface (2013) 1.09
Chemical basis of interactions between engineered nanoparticles and biological systems. Chem Rev (2014) 1.07
Comparison of nanotube-protein corona composition in cell culture media. Small (2013) 1.06
Adsorption of surfactant lipids by single-walled carbon nanotubes in mouse lung upon pharyngeal aspiration. ACS Nano (2012) 1.04
Microsomal glutathione transferase 1 protects against toxicity induced by silica nanoparticles but not by zinc oxide nanoparticles. ACS Nano (2012) 0.98
Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo. PLoS One (2011) 0.96
Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes. Int J Nanomedicine (2011) 0.95
Identifying new therapeutic targets via modulation of protein corona formation by engineered nanoparticles. PLoS One (2012) 0.95
A combined theoretical and in vitro modeling approach for predicting the magnetic capture and retention of magnetic nanoparticles in vivo. J Control Release (2011) 0.92
Cellular Binding of Anionic Nanoparticles is Inhibited by Serum Proteins Independent of Nanoparticle Composition. Biomater Sci (2013) 0.91
An experimental and theoretical analysis of molecular separations by diffusion through ultrathin nanoporous membranes. J Memb Sci (2011) 0.91
Quantitative profiling of the protein coronas that form around nanoparticles. Nat Protoc (2014) 0.89
Formation of nano-bio-complex as nanomaterials dispersed in a biological solution for understanding nanobiological interactions. Sci Rep (2012) 0.89
Protein bio-corona: critical issue in immune nanotoxicology. Arch Toxicol (2016) 0.87
Nanoscale interfaces to biology. Curr Opin Chem Biol (2010) 0.85
Molecular modeling in structural nano-toxicology: interactions of nano-particles with nano-machinery of cells. Adv Drug Deliv Rev (2013) 0.84
The effect of blood protein adsorption on cellular uptake of anatase TiO2 nanoparticles. Int J Nanomedicine (2015) 0.83
TAT and HA2 facilitate cellular uptake of gold nanoparticles but do not lead to cytosolic localisation. PLoS One (2015) 0.83
Nanomaterials toxicity and cell death modalities. J Drug Deliv (2012) 0.82
Cyclic stretch of alveolar epithelial cells alters cytoskeletal micromechanics. Biotechnol Bioeng (2011) 0.82
Merging worlds of nanomaterials and biological environment: factors governing protein corona formation on nanoparticles and its biological consequences. Nanoscale Res Lett (2015) 0.81
Assembly of bio-nanoparticles for double controlled drug release. PLoS One (2013) 0.80
Low molecular weight chitosan-coated polymeric nanoparticles for sustained and pH-sensitive delivery of paclitaxel. J Drug Target (2015) 0.79
Heterogeneity in nanoparticles influences biodistribution and targeting. Nanomedicine (Lond) (2013) 0.78
Differential Protein Adsorption and Cellular Uptake of Silica Nanoparticles Based on Size and Porosity. ACS Appl Mater Interfaces (2016) 0.76
Proteomics Analysis Reveals Distinct Corona Composition on Magnetic Nanoparticles with Different Surface Coatings: Implications for Interactions with Primary Human Macrophages. PLoS One (2015) 0.76
Toward a molecular understanding of nanoparticle-protein interactions. Biophys Rev (2012) 0.76
Tight junction between endothelial cells: the interaction between nanoparticles and blood vessels. Beilstein J Nanotechnol (2016) 0.75
Peptide-biphenyl hybrid-capped AuNPs: stability and biocompatibility under cell culture conditions. Nanoscale Res Lett (2013) 0.75
Recent progress on magnetic nanoparticles for magnetic hyperthermia. Prog Biomater (2016) 0.75
Serum protein adsorption and excretion pathways of metal nanoparticles. Nanomedicine (Lond) (2015) 0.75
Ultrasonic mediated synthesis of monodispersed lanthanum hydroxide nanorods for possible bioimplant application. J Mater Sci Mater Med (2015) 0.75
Safe handling of nanotechnology. Nature (2006) 7.25
Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. J Cereb Blood Flow Metab (2006) 3.35
Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect (2006) 3.16
Charge- and size-based separation of macromolecules using ultrathin silicon membranes. Nature (2007) 3.01
A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease. J Clin Invest (2012) 2.98
Ultrafine particle deposition in humans during rest and exercise. Inhal Toxicol (2003) 2.06
Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs. Inhal Toxicol (2009) 1.78
Ultrafine particles in the urban air: to the respiratory tract--and beyond? Environ Health Perspect (2002) 1.76
Efficient elimination of inhaled nanoparticles from the alveolar region: evidence for interstitial uptake and subsequent reentrainment onto airways epithelium. Environ Health Perspect (2007) 1.65
Meeting report: hazard assessment for nanoparticles--report from an interdisciplinary workshop. Environ Health Perspect (2007) 1.64
Radiation pneumonitis and early circulatory cytokine markers. Semin Radiat Oncol (2002) 1.62
Does Nanoparticle Activity Depend upon Size and Crystal Phase? Nanotoxicology (2008) 1.62
Concept of assessing nanoparticle hazards considering nanoparticle dosemetric and chemical/biological response metrics. J Toxicol Environ Health A (2010) 1.61
Sheet migration by wounded monolayers as an emergent property of single-cell dynamics. J Cell Sci (2007) 1.60
Type II epithelial cells are critical target for hyperoxia-mediated impairment of postnatal lung development. Am J Physiol Lung Cell Mol Physiol (2006) 1.58
SIRT1 is a redox-sensitive deacetylase that is post-translationally modified by oxidants and carbonyl stress. FASEB J (2010) 1.54
Interlaboratory evaluation of rodent pulmonary responses to engineered nanomaterials: the NIEHS Nano GO Consortium. Environ Health Perspect (2013) 1.52
Correlating physico-chemical with toxicological properties of nanoparticles: the present and the future. ACS Nano (2010) 1.49
Pulmonary function, diffusing capacity, and inflammation in healthy and asthmatic subjects exposed to ultrafine particles. Inhal Toxicol (2004) 1.45
Inhalation of ultrafine particles alters blood leukocyte expression of adhesion molecules in humans. Environ Health Perspect (2006) 1.44
Ultrafine particle deposition in subjects with asthma. Environ Health Perspect (2004) 1.40
Cationic nanoparticles disrupt cellular signaling in a cholesterol dependent manner. Toxicol In Vitro (2012) 1.40
Radiation-induced pulmonary fibrosis: examination of chemokine and chemokine receptor families. Radiat Res (2002) 1.36
Effects of subchronically inhaled carbon black in three species. I. Retention kinetics, lung inflammation, and histopathology. Toxicol Sci (2005) 1.30
The rat ear vein model for investigating in vivo thrombogenicity of ultrafine particles (UFP). Toxicol Sci (2005) 1.29
Activated integrin VLA-4 localizes to the lamellipodia and mediates T cell migration on VCAM-1. J Immunol (2009) 1.28
Effects of exposure to ultrafine carbon particles in healthy subjects and subjects with asthma. Res Rep Health Eff Inst (2004) 1.25
Equivalent titanium dioxide nanoparticle deposition by intratracheal instillation and whole body inhalation: the effect of dose rate on acute respiratory tract inflammation. Part Fibre Toxicol (2014) 1.24
Pneumocystis carinii activates the NF-kappaB signaling pathway in alveolar epithelial cells. Infect Immun (2005) 1.24
Identification and isolation of mouse type II cells on the basis of intrinsic expression of enhanced green fluorescent protein. Am J Physiol Lung Cell Mol Physiol (2003) 1.22
Translocation and effects of ultrafine particles outside of the lung. Clin Occup Environ Med (2006) 1.20
The role of substrate curvature in actin-based pushing forces. Curr Biol (2004) 1.18
Changes in deceleration capacity of heart rate and heart rate variability induced by ambient air pollution in individuals with coronary artery disease. Part Fibre Toxicol (2010) 1.16
A structure-permeability relationship of ultrathin nanoporous silicon membrane: a comparison with the nuclear envelope. J Am Chem Soc (2008) 1.15
Essential role of cofilin-1 in regulating thrombin-induced RelA/p65 nuclear translocation and intercellular adhesion molecule 1 (ICAM-1) expression in endothelial cells. J Biol Chem (2009) 1.13
Inflammatory cell recruitment following thoracic irradiation. Exp Lung Res (2004) 1.12
Concepts of nanoparticle dose metric and response metric. Environ Health Perspect (2007) 1.12
Continued controversy on chrysotile biopersistence. Int J Occup Environ Health (2011) 1.12
Recombinant human activated protein C inhibits integrin-mediated neutrophil migration. Blood (2009) 1.11
Blocking S-adenosylmethionine synthesis in yeast allows selenomethionine incorporation and multiwavelength anomalous dispersion phasing. Proc Natl Acad Sci U S A (2007) 1.11
The origin, fate, and health effects of combustion by-products: a research framework. Environ Health Perspect (2002) 1.10
Nanotoxicology: in vitro-in vivo dosimetry. Environ Health Perspect (2012) 1.09
Effect of administration of lovastatin on the development of late pulmonary effects after whole-lung irradiation in a murine model. Radiat Res (2004) 1.08
Evidence for actin cytoskeleton-dependent and -independent pathways for RelA/p65 nuclear translocation in endothelial cells. J Biol Chem (2006) 1.07
Systemic effects of inhaled ultrafine particles in two compromised, aged rat strains. Inhal Toxicol (2004) 1.04
Treatment for radiation-induced pulmonary late effects: spoiled for choice or looking in the wrong direction? Curr Drug Targets (2010) 1.03
Recirculating air filtration significantly reduces exposure to airborne nanoparticles. Environ Health Perspect (2008) 1.03
Activation of pulmonary dendritic cells and Th2-type inflammatory responses on instillation of engineered, environmental diesel emission source or ambient air pollutant particles in vivo. J Innate Immun (2010) 1.03
Validation of an LDH assay for assessing nanoparticle toxicity. Toxicology (2011) 1.03
A comparative dose-related response of several key pro- and antiinflammatory mediators in the lungs of rats, mice, and hamsters after subchronic inhalation of carbon black. J Occup Environ Med (2006) 1.03
ECG parameters and exposure to carbon ultrafine particles in young healthy subjects. Inhal Toxicol (2009) 1.02
Early alterations in cytokine expression in adult compared to developing lung in mice after radiation exposure. Radiat Res (2010) 1.01
Induction of chemokines by low-dose intratracheal silica is reduced in TNFR I (p55) null mice. Toxicol Sci (2003) 1.01
In vivo cardioprotection by S-nitroso-2-mercaptopropionyl glycine. J Mol Cell Cardiol (2009) 1.01
A nanoparticle dispersion method for in vitro and in vivo nanotoxicity study. Nanotoxicology (2010) 1.00
On-road exposure to highway aerosols. 2. Exposures of aged, compromised rats. Inhal Toxicol (2004) 0.98
β-adrenergic receptor stimulation transactivates protease-activated receptor 1 via matrix metalloproteinase 13 in cardiac cells. Circulation (2012) 0.97
Comparing inhaled ultrafine versus fine zinc oxide particles in healthy adults: a human inhalation study. Am J Respir Crit Care Med (2005) 0.97
Early postnatal exposure to ultrafine particulate matter air pollution: persistent ventriculomegaly, neurochemical disruption, and glial activation preferentially in male mice. Environ Health Perspect (2014) 0.97
High-performance separation of nanoparticles with ultrathin porous nanocrystalline silicon membranes. ACS Nano (2010) 0.96
Reactive oxidant and p42/44 MAP kinase signaling is necessary for mechanical strain-induced proliferation in pulmonary epithelial cells. J Appl Physiol (1985) (2005) 0.96
Binding between particles and proteins in extracts: implications for microrheology and toxicity. Acta Biomater (2005) 0.95
Cyclooxygenase-2 independent effects of cyclooxygenase-2 inhibitors on oxidative stress and intracellular glutathione content in normal and malignant human B-cells. Cancer Immunol Immunother (2007) 0.95
Effect of total body irradiation on late lung effects: hidden dangers. Int J Radiat Biol (2011) 0.95
Neonatal oxygen increases sensitivity to influenza A virus infection in adult mice by suppressing epithelial expression of Ear1. Am J Pathol (2012) 0.94
Ion-selective permeability of an ultrathin nanoporous silicon membrane as probed by scanning electrochemical microscopy using micropipet-supported ITIES tips. Anal Chem (2010) 0.93
Mitogen- and stress-activated kinase 1 (MSK1) regulates cigarette smoke-induced histone modifications on NF-κB-dependent genes. PLoS One (2012) 0.93
Alveolar epithelial cell-macrophage interactions affect oxygen-stimulated interleukin-8 release. Inflammation (2003) 0.93
Nanoparticle (NP) uptake by type I alveolar epithelial cells and their oxidant stress response. Nanotoxicology (2009) 0.92
Developmental exposure to concentrated ambient particles and preference for immediate reward in mice. Environ Health Perspect (2012) 0.92
SIRT1 protects against cigarette smoke-induced lung oxidative stress via a FOXO3-dependent mechanism. Am J Physiol Lung Cell Mol Physiol (2014) 0.91
Membrane mobility of beta2 integrins and rolling associated adhesion molecules in resting neutrophils. Biophys J (2008) 0.91
Application of an informatics-based decision-making framework and process to the assessment of radiation safety in nanotechnology. Health Phys (2015) 0.91
p21Cip1 protection against hyperoxia requires Bcl-XL and is uncoupled from its ability to suppress growth. Am J Pathol (2006) 0.91
Parenchymal cell TNF receptors contribute to inflammatory cell recruitment and respiratory failure in Pneumocystis carinii-induced pneumonia. J Immunol (2008) 0.90
Effects of on-road highway aerosol exposures on autonomic responses in aged, spontaneously hypertensive rats. Inhal Toxicol (2007) 0.90
Short-term effects of air pollution: a panel study of blood markers in patients with chronic pulmonary disease. Part Fibre Toxicol (2009) 0.90
Extraction and quantification of carbon nanotubes in biological matrices with application to rat lung tissue. ACS Nano (2013) 0.89
Dense display of HIV-1 envelope spikes on the lambda phage scaffold does not result in the generation of improved antibody responses to HIV-1 Env. Vaccine (2011) 0.89
Time course of lung retention and toxicity of inhaled particles: short-term exposure to nano-Ceria. Arch Toxicol (2014) 0.88
Activation of the G2 cell cycle checkpoint enhances survival of epithelial cells exposed to hyperoxia. Am J Physiol Lung Cell Mol Physiol (2002) 0.88
Micronutrient levels in children exposed to secondhand tobacco smoke. Nicotine Tob Res (2011) 0.87
Comparison of tracheal aspirate and bronchoalveolar lavage specimens from premature infants. Biol Neonate (2002) 0.86
Ultrathin silicon membranes for wearable dialysis. Adv Chronic Kidney Dis (2013) 0.86
Exacerbation of lung radiation injury by viral infection: the role of Clara cells and Clara cell secretory protein. Radiat Res (2013) 0.86
Sequential exposures to ozone and lipopolysaccharide in postnatal lung enhance or inhibit cytokine responses. Exp Lung Res (2005) 0.86
Assessing the relevance of in vitro studies in nanotoxicology by examining correlations between in vitro and in vivo data. Toxicology (2012) 0.86
Endotoxin potentiates ozone-induced pulmonary chemokine and inflammatory responses. Exp Lung Res (2002) 0.86
Impact of ambient air pollution on the differential white blood cell count in patients with chronic pulmonary disease. Inhal Toxicol (2010) 0.86
Cardiolipin biosynthesis in Streptococcus mutans is regulated in response to external pH. Microbiology (2012) 0.85
Highly permeable silicon membranes for shear free chemotaxis and rapid cell labeling. Lab Chip (2014) 0.85
Formation of PAH-DNA adducts after in vivo and vitro exposure of rats and lung cells to different commercial carbon blacks. Toxicol Appl Pharmacol (2005) 0.85
Postnatal lung development: immediate-early gene responses post ozone and LPS exposure. Inhal Toxicol (2006) 0.85